FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma
Ananda Pharma reports Phase 1 pharmacokinetic study results for MRX1
NMD Pharma reports further data from Phase 2a study of ignaseclant
Gesynta Pharma reports progress in Phase 2 trial of vipoglanstat
Bayer completes acquisition of Perfuse Therapeutics to strengthen ophthalmology pipeline
Akeso reports Phase II data for ligufalimab in AML
Optimi Health introduces standardised microdose psilocybin capsules for clinical research
Lilly acquires 4E Therapeutics to advance non-opioid chronic pain treatment
AlzeCure reports positive Phase Ib results for Alzheimer's candidate ACD856
Minghui Pharmaceutical presents MHB018A Phase I/II results for thyroid eye disease at ENDO 2026